Results of Unicompartmental Knee Arthroplasties in Patients Beyond Historical Indications (PUCIL)
NCT ID: NCT05749965
Last Updated: 2023-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
522 participants
OBSERVATIONAL
2023-03-31
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To compare medial uni compartimental knee arthroplasty between patients who had a limit factor prior to the surgery ans patients who fill thé historical criteria.
Secondary objectives
1 to compare survival of medial UKA between patients with one limit factor and those with multiple limits.
2\. To identify the prognosis factors of failure in medial UKA in our center during the time of our analysis (2009-2015)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Clinical and Radiographic Results of a Fixed Polyethylene Posteriorly Stabilized Cemented Total Knee Prosthesis With a Minimum Follow-up of 1 Year.
NCT07313449
Results of a Mobile Unicompartimental Knee Prosthesis
NCT03130309
Comparison of Pivotal Medial Polyethylene Versus Ultra-congruent in Total Knee Arthroplasty
NCT06676189
Long-term Evaluation Protocol (12 Months Postoperative) of Total Knee Prostheses Anatomic With Resurfaced Patella Versus Non-resurfaced Patella in Patients Requiring Total Knee Arthroplasty
NCT03081260
Functional Knee Phenotypes of Patients Operated on for Total Knee Arthroplasty
NCT05380206
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Limit indications
Obèse (BMI\>30), ACL déficiency, HKA \> 10°, flessum \>10° \[HKA : hop knee angle\]
Unicompartmental knee arthroplasty
medial unicompartmental knee arthroplasty
Historical indications
Patient with a BMI between 18,5 and 30, HKA \<10°, functionnal ACL, no flessum or \<5°
Unicompartmental knee arthroplasty
medial unicompartmental knee arthroplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Unicompartmental knee arthroplasty
medial unicompartmental knee arthroplasty
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* lost to follow up
* patient refuses
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
FERNANDEZ Andrea
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andre Fernandez
Role: STUDY_DIRECTOR
Central Hospital, Nancy, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Chirurgical Emile Gallé
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022PI091
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.